CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA

This adverse event was reported 12 times

CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN RHO(D) IMMUNE GLOBULIN 2 0.0019
1 METHYLDOPA 1 0.0002
2 HUMAN INSULIN 1 0.0001
3 MIRTAZAPINE 4 0.0000
4 NIFEDIPINE 1 0.0000
5 METFORMIN HYDROCHLORIDE TABLETS 1 0.0000
6 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 1 0.0000
7 METFORMIN HYDROCHLORIDE TABLET 1 0.0000
8 METFORMIN HYDROCHLORIDE 1 0.0000
9 METFORMIN ER 500 MG 2 0.0000
See all drugs enriched for association with CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA

CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 2 0.0001
1 Insulin [EPC] 1 0.0000
2 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
3 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 2 0.0000
See all drug classes enriched for association with CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA